SearchDictionaryMobileLogin

Retained Placenta

Subscribe to Selected New Research on Retained Placenta
243  relevant articles (15 outcomes, 32 trials/studies) found for this Disease

Description: A placenta that fails to be expelled after BIRTH of the FETUS. A PLACENTA is retained when the UTERUS fails to contract after the delivery of its content, or when the placenta is abnormally attached to the MYOMETRIUM.

Also Known As:
Placenta, Retained; Placentas, Retained; Retained Placentas

Relationship Network

Disease Context: Research Results

-
Female Urogenital Diseases and Pregnancy Complications
-
Pregnancy Complications: 552
-
Placenta Diseases: 15
*
Retained Placenta: 243

Related Diseases

1. Mastitis
2. Infection
3. Pain (Aches)
4. Postpartum Hemorrhage
5. Endometritis

Experts

1. Kankofer, M: 4 articles (02/2004 - 05/2001)
2. Wierciński, J: 2 articles (02/2004 - 04/2002)
3. Gustafsson, H: 2 articles (02/2002 - 10/2001)
4. Kindahl, H: 2 articles (02/2002 - 10/2001)
5. Königsson, K: 2 articles (02/2002 - 10/2001)
6. Yin, C S: 2 articles (12/2001 - 08/2001)
7. Li, Y T: 2 articles (12/2001 - 08/2001)
8. Ekerhovd, Erling: 1 article (01/2008)
9. Bullarbo, Maria: 1 article (01/2008)
10. Everts, M E: 1 article (07/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Retained Placenta:
1. Vitamin EFDA Link
2. Oxytocin (Pitocin)FDA LinkGeneric
3. Nitroglycerin (Dynamite)FDA LinkGeneric
4. Collagenases (Collagenase)FDA Link
5. Misoprostol (Cytotec)FDA LinkGeneric
6. DinoprostIBA
7. Oxytetracycline (Terramycin)FDA Link
8. fenprostaleneIBA
9. SeleniumIBA
10. Sodium Chloride (Saline Solution)FDA LinkGeneric

Therapies and Procedures

1. Injections
2. Dilatation and Curettage (D&C)
07/01/2008 - "Independent risk factors associated with retained placenta include non-use of antenatal care (odds-ratio [OR] 22.71, 95 percent confidence interval [CI] 10.5-49.12, p-value is less than 0.000), previous retained placenta (OR 15.22, 95 percent CI 3.30-70.19, p-value is less than 0.000), previous caesarean section (OR 12.00, 95 percent CI 2.05-70.19, p-value is less than 0.006), maternal age 35 years or more (OR 7.10, 95 percent CI 1.5-32.40, p-values is less than 0.012), grand multiparity (OR 6.63, 95 percent CI 1.88-23.40, p-value is less than 0.003), previous dilatation and curettage (OR 4.44, 95 percent CI 1.69-11.63, p-value is less than 0.002), preterm delivery (OR 3.12, 95 percent CI 1.12-8.68, p-value is less than 0.029) and placenta weight less than 501 g (OR 2.91, 95 percent CI 1.34-6.32, p-value is less than 0.007). "
03/01/2006 - "Evacuation of the retained placenta resulted in septic shock, which occurred immediately after dilatation and curettage. "
11/01/2005 - "Secondary outcome measures were the rate of dilatation and curettage (D&C) for retained placenta and the rates of fever and gastrointestinal complications. "
10/01/2003 - "An hour after delivery the patient began complaining of syncope; at this time bleeding was greater than expected and the obstetrician decided a dilatation and curettage for retained placenta was necessary. "
11/01/2005 - "The rate of retained placenta requiring D&C was significantly greater in the PGF2alpha group (22.4% vs. 3.4%, P = 0.002). "
Order ALL the reference details at left...
3. Anesthesia
4. Cesarean Section (Caesarean Section)
5. Induced Abortion (Induced Abortions)

Best Treatments:
Research Summary Report
on Retained Placenta
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 15 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>